Business programme 2021
Vitamin and Dietary Supplements Market: Russia Keeping Up with Global Trends
Panel session
Session sponsored by RBC
The issue of the conscious intake of vitamins and bioactive supplements has long been raised by both the medical community and the manufacturers of these drugs, who value their reputation and promote the idea of smart consumption. The coronavirus pandemic has served as sort of catalyst for this process, since many countries at the national level have realized the need for the vitamin fortification of the population.
Russia is no exception. Doctors share the opinion that the proper intake of vitamins and dietary supplements has a positive effect on the overall strengthening of a person’s immunity. Consumers’ attitude towards dietary supplements has also changed; polling has recorded increased consumer confidence in this group of drugs. The vitamin and mineral products market reacted instantly to the global trend: demand increased by 40% in 2020, as the market was worth around RUB 56 billion. This year, the situation is repeating itself. In January 2021, sales of vitamins and dietary supplements increased by 50% compared with last January.
The time has now come to think about how to fortify the population with vitamins. Is there a need for government policy with strict quality standards? Can we utilize the experience of the Soviet Union, where this work was carried out on a systematic basis? Who should think about the vitamin consumption culture and how? What steps should be taken to improve awareness-raising among the population on the proper intake of vitamins and dietary supplements?
Discussion topics:
• Global trends in vitamin fortification: is Russia keeping up?
• Growth in vitamin and dietary supplement sales in Russia and around the world – is this a global trend or a consequence of the pandemic?
• Whose job is it to enhance the culture of vitamin consumption?
• How can we ensure the availability of the highest quality vitamins and dietary supplements for the Russian market?
Russia is no exception. Doctors share the opinion that the proper intake of vitamins and dietary supplements has a positive effect on the overall strengthening of a person’s immunity. Consumers’ attitude towards dietary supplements has also changed; polling has recorded increased consumer confidence in this group of drugs. The vitamin and mineral products market reacted instantly to the global trend: demand increased by 40% in 2020, as the market was worth around RUB 56 billion. This year, the situation is repeating itself. In January 2021, sales of vitamins and dietary supplements increased by 50% compared with last January.
The time has now come to think about how to fortify the population with vitamins. Is there a need for government policy with strict quality standards? Can we utilize the experience of the Soviet Union, where this work was carried out on a systematic basis? Who should think about the vitamin consumption culture and how? What steps should be taken to improve awareness-raising among the population on the proper intake of vitamins and dietary supplements?
Discussion topics:
• Global trends in vitamin fortification: is Russia keeping up?
• Growth in vitamin and dietary supplement sales in Russia and around the world – is this a global trend or a consequence of the pandemic?
• Whose job is it to enhance the culture of vitamin consumption?
• How can we ensure the availability of the highest quality vitamins and dietary supplements for the Russian market?
Taking a National Healthcare to a Whole New Level: Creating Medical Ecosystems
Panel session
Nowadays, success or failure of a medical institution is assessed depending on the quality of services it rendered. Finding a balance between usefulness to a specific patient, the use of leading treatment protocols and standards, and economic considerations is becoming top priority. That said, the volume of medical information in the world is doubled every 2.5 months. The term ‘digital healthcare’ is gradually fading out because absolutely all healthcare now works digitally. In these circumstances, it is not enough for a medical company to simply hire marketing or digital experts. What is needed is a union of separate industry players, each of which has a market niche, a wide store of skills, an organizational structure, and industry connections. Such a system must be fully integrated: on the level of communications, shared understanding of the specific character of the business, shared data, control processes, accounting and budgeting, and so on. Only in that case, such an ecosystem as Connected Health Enterprise can function as a single body.
● How will the growing ecosystem demand impact the balance of power on the market?
● Are we heading toward risks of monopolization?
● Is building ecosystems solely the privilege of the government and institutional players?
● Should we expect radical changes in the labour market?
● Is the current medical education system at risk of going out of date?
● Does international practice have answers to these questions?
Yury Krestinskiy — Chairman of the Board of Directors, Institute for Public Health Development; Vice President - Head of Healthcare Industry, Sberbank
Oksana Monge — General Director, Sanofi Russia
Sergey Notov — President, MedInvestGroup
Airat Farrakhov — Deputy, Deputy Chairman of the Commission of the State Duma of the Federal Assembly of the Russian Federation for Support of the Development of Small- and Medium-sized Business
Ivan Ozhgikhin — Senior Managing Director, Business Development Centre, RUSNANO Management Company; Chairman of the Board, Medical Technology Consortium
● How will the growing ecosystem demand impact the balance of power on the market?
● Are we heading toward risks of monopolization?
● Is building ecosystems solely the privilege of the government and institutional players?
● Should we expect radical changes in the labour market?
● Is the current medical education system at risk of going out of date?
● Does international practice have answers to these questions?
Moderator:
Ivan Tyagoun — Head of Consulting, Head of Public Sector, KPMG in Russia and the CIS
Panellists:
Natalia Komarova — General Director, Rusatom Healthcare
Yury Krestinskiy — Chairman of the Board of Directors, Institute for Public Health Development; Vice President - Head of Healthcare Industry, Sberbank
Since 2016: head of research centre for economics and management in healthcare at the Skolkovo management school in Moscow. The centre's primary objective is to conduct research on effective management, economics and informational support for Russia's healthcare system and to create and implement educational programmes promoting development of professional healthcare managers. Since 2007: Director of Institute of Public Healthcare Development. Key recent project: Moscow Medical Cluster. 1993 foundation of the Bionika group, CEO. 2007: headed the Department of Pharmaceutical Activities, Regional and Information Policy at the Ministry of Health and Social Development of the Russian Federation. Apart from the activities covered by the name of the department, supervised development of high-tech medical care in the Russian Federation and engaged foreign specialists. Civil engagement: Since 2003: member of the coordinating council of the Russian Association of Pharmacy Chains. Since 1999: co-chairman of the coordinating council of the Russian Association for Pharmaceutical Marketing. 1995–2002: Association of Commercial Pharmaceutical Organizations PharmAsk, Deputy CEO. Works with the Institute of Public Healthcare Development and various professional committees under different government agencies. Has a versatile investment portfolio including projects in film, fitness (he is also an instructor in qigong and tai chi), fresh water supply, R&D of new medical products, venture projects, etc. Promotes young entrepreneurs. Has five children.
Oksana Monge — General Director, Sanofi Russia
Sergey Notov — President, MedInvestGroup
Born: 29 September 1973
Place of Birth: Kuybyshev, Novosibirskaya oblast, Russia
Marital status: married
Children: daughter
• In 1995 graduated from Tomsk State University, Faculty of Law.
• Business career started in Central City Hospital of Noyabrsk, as head of medical insurance department.
• 1999 – civil servant in Administration of Noyabrsk.
• 2005 - founded IPT Group.
• 2005 – Chairman of the Board, IPT Group.
• 2011 - Chairman of the Board at PAO «К+31», one of 25 top Russian medical centers in Russia according to RBC.
• 2016 - IPT Group rated by Pravo-300. IPT Group rated 21 among top Russian law firms.
• 2017 - IPT Group has been chosen as the winner of the 2017 Corporate Intl Magazine Global Award in 2 nominations ‘Pharmaceuticals & Life Sciences Law Firm of the Year in Russia’and “M&A Lawyer of the Year in Russia”.
Facts
• 2015 – FBO RIGA business jet hub successfully completed.
• 2015 – a complex project completed for conclusion of concession agreements aimed at creation of oncologic radiology centers in Moscow oblast.
• 2016 - private medical clinic “Petrovskiye Vorota” merged into the network of clinics «К+31», manages by IPT Group.
• 2016 - successful creation of the first Russian JV. The largest pharmaceuticals manufacturing localization project in Russia.
Place of Birth: Kuybyshev, Novosibirskaya oblast, Russia
Marital status: married
Children: daughter
• In 1995 graduated from Tomsk State University, Faculty of Law.
• Business career started in Central City Hospital of Noyabrsk, as head of medical insurance department.
• 1999 – civil servant in Administration of Noyabrsk.
• 2005 - founded IPT Group.
• 2005 – Chairman of the Board, IPT Group.
• 2011 - Chairman of the Board at PAO «К+31», one of 25 top Russian medical centers in Russia according to RBC.
• 2016 - IPT Group rated by Pravo-300. IPT Group rated 21 among top Russian law firms.
• 2017 - IPT Group has been chosen as the winner of the 2017 Corporate Intl Magazine Global Award in 2 nominations ‘Pharmaceuticals & Life Sciences Law Firm of the Year in Russia’and “M&A Lawyer of the Year in Russia”.
Facts
• 2015 – FBO RIGA business jet hub successfully completed.
• 2015 – a complex project completed for conclusion of concession agreements aimed at creation of oncologic radiology centers in Moscow oblast.
• 2016 - private medical clinic “Petrovskiye Vorota” merged into the network of clinics «К+31», manages by IPT Group.
• 2016 - successful creation of the first Russian JV. The largest pharmaceuticals manufacturing localization project in Russia.
Airat Farrakhov — Deputy, Deputy Chairman of the Commission of the State Duma of the Federal Assembly of the Russian Federation for Support of the Development of Small- and Medium-sized Business
Work experience
State Duma of the Federal Assembly Russian Federation, Moscow, Russia:
Member of the State Duma VII convocation, committee on budget and taxes
• Chairman of the subcommittee on:
• Budget for the Russian pension fund
• Federal Fund for Compulsory Health Insurance
• Social Security Fund budget
Ministry of Finances of Russia, Moscow, Russia:
The Deputy Minister
• Budgetary activities in healthcare, civil sciences, culture, education, physical culture and sports, tourism, youth policy, pensions and social security for civilians, social insurance, employment; in the 2014 Olympic Winter Games in Sochi, the preparation and hosting of the 2018 FIFA World Cup.
Ministry of Health care of Russia, Moscow, Russia:
The Deputy Minister
• Healthcare industry finances (obligatory investments, federal and regional budget, private investments)
• Health care digitalization
Ministry of Health care of republic of Tatarstan, Kazan, Russia:
The Minister, member of government board of republic of Tatarstan
• Ensured an increase in the volume of high-tech medical care by three times, reduced the incidence of child morbidity and mortality, increased life expectancy due to a decrease in mortality
• Reformed the structure of medical care by optimizing inefficient medical organizations, restructuring the financial support for the program of state guarantees
State Duma of the Federal Assembly Russian Federation, Moscow, Russia:
Member of the State Duma VII convocation, committee on budget and taxes
• Chairman of the subcommittee on:
• Budget for the Russian pension fund
• Federal Fund for Compulsory Health Insurance
• Social Security Fund budget
Ministry of Finances of Russia, Moscow, Russia:
The Deputy Minister
• Budgetary activities in healthcare, civil sciences, culture, education, physical culture and sports, tourism, youth policy, pensions and social security for civilians, social insurance, employment; in the 2014 Olympic Winter Games in Sochi, the preparation and hosting of the 2018 FIFA World Cup.
Ministry of Health care of Russia, Moscow, Russia:
The Deputy Minister
• Healthcare industry finances (obligatory investments, federal and regional budget, private investments)
• Health care digitalization
Ministry of Health care of republic of Tatarstan, Kazan, Russia:
The Minister, member of government board of republic of Tatarstan
• Ensured an increase in the volume of high-tech medical care by three times, reduced the incidence of child morbidity and mortality, increased life expectancy due to a decrease in mortality
• Reformed the structure of medical care by optimizing inefficient medical organizations, restructuring the financial support for the program of state guarantees
Ildar Khayrullin — General Director, International Medical Cluster Foundation
Front row participants:
Sergey Bushnev — Deputy Development Director, Priorov Central Scientific Institute of Traumatology and Orthopaedics Federal State Budgetary Institution under the Ministry of Health of the Russian Federation
Herman Inozemtsev — General Director, Santens Group of Companies
Ivan Ozhgikhin — Senior Managing Director, Business Development Centre, RUSNANO Management Company; Chairman of the Board, Medical Technology Consortium
Ivan Ozhgikhin was born on June 6, 1976 in the city of Kurgan. In 1998 he graduated from the Kurgan State Agricultural Academy with a degree in Accounting and Audit. In 2004 he got a second higher education from the Ural Federal University named after the first President of Russia B.Yeltsin with specialization in Management.
In 2000 he began his career with OJSC "Production Association Ural Optical and Mechanical Plant named after E.S. Yalamov” as an economist. In 2013, he was approved in the position of Director of Shvabe-Moscow LLC.
In 2016, Ivan Ozhgikhin was appointed Deputy General Director of Shvabe Holding (Development of Sales, Marketing and Service Support Systems for Civil Products).
Ivan Ozhgikhin is a Corresponding Member of the Academy of Medical and Technical Sciences, President of the non-profit partnership "International Association of Developers, Manufacturers and Users of Medical Equipment".
In 2000 he began his career with OJSC "Production Association Ural Optical and Mechanical Plant named after E.S. Yalamov” as an economist. In 2013, he was approved in the position of Director of Shvabe-Moscow LLC.
In 2016, Ivan Ozhgikhin was appointed Deputy General Director of Shvabe Holding (Development of Sales, Marketing and Service Support Systems for Civil Products).
Ivan Ozhgikhin is a Corresponding Member of the Academy of Medical and Technical Sciences, President of the non-profit partnership "International Association of Developers, Manufacturers and Users of Medical Equipment".
Vladislav Sherstoboev — Chief Executive Officer, GK "Expert"
Affordable Quality: Opportunities and Risks of Developing the Generics Market in Russia
Panel session
Session sponsored by RBC
Trust in a brand, price, quality. These are the key principles of success on any market and the pharmaceutical market is no exception. Boosting the availability and efficiency of drugs is one of the key national healthcare goals, which is precisely why the generics market in Russia is actively growing and developing.
Meanwhile, the share of generics on the pharmaceutical markets of Germany and the United Kingdom is as high as 75%, yet this figure is only 45% in Russia. How can this indicator be increased and how can we meet the demand for high-quality and affordable drugs in Russia?
The domestic generics market remains a promising and significant one for manufacturers, investors, and consumers, but there are some key regulatory issues in pricing, patent laws, and public procurements that need to be addressed to support the sustainable development of this market.
• What resources do companies need in order to develop the production of affordable drugs?
• What mechanisms can help come up with productive solutions when developing the generics market in Russia?
• How can the national healthcare system and the end-user benefit from the expansion of the generic drug line?
Meanwhile, the share of generics on the pharmaceutical markets of Germany and the United Kingdom is as high as 75%, yet this figure is only 45% in Russia. How can this indicator be increased and how can we meet the demand for high-quality and affordable drugs in Russia?
The domestic generics market remains a promising and significant one for manufacturers, investors, and consumers, but there are some key regulatory issues in pricing, patent laws, and public procurements that need to be addressed to support the sustainable development of this market.
• What resources do companies need in order to develop the production of affordable drugs?
• What mechanisms can help come up with productive solutions when developing the generics market in Russia?
• How can the national healthcare system and the end-user benefit from the expansion of the generic drug line?
Biotechnology Entrepreneurship. Can Unicorns Exist in Russia?
(Session sponsored by Skolkovo Innovation Centre)
The pandemic has had a huge impact on transformation of biotechnological innovations. Russian scientists have already demonstrated their prowess to the global scientific and business communities when the first ever coronavirus vaccine Sputnik V was registered in August 2020. To become a ‘unicorn’ in biotechnology, a startup needs to offer the market an entirely new product or present a significant transformation of an existing one. In global practice, it is becoming common practice when biotechnological innovations are created in cooperation: science and market go for maximum partnership. Lately, large industrial corporations in Russia work together with biotechnology startups to create incubation and acceleration programmes for start-ups, tailored to the needs of the market. Using the opportunities provided by these accelerators, young scientists, guided by the industry, hone their entrepreneurial skills, develop innovative technologies under the auspices of medical clinics, learn to attract investment, and receive mentoring support from the experts.
● How can the existing start-ups be sustained in Russia, new ones grown, and what is needed to take Russian innovations to the international arena?
● What conditions need to be created for inflow of investment to biotechnological startups?
● What should the integration of government, universities, labs, and industrial partners be like?
● What do innovation startups focus on now?
Pekka Viljakainen — Advisor to the Chairman of the Board of Directors, Skolkovo Foundation; Chairman, Aii Capital
Arkady Dvorkovich — Chairman, Skolkovo Foundation
Igor Korobko — Head of Science and Innovative Development of Health Department, Ministry of Health of the Russian Federation
(online)
Dmitry Kudlay — General Director, Generium
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Sergei Sorokin — General Director, Intellogic LLC; Founder, Botkin.AI
● How can the existing start-ups be sustained in Russia, new ones grown, and what is needed to take Russian innovations to the international arena?
● What conditions need to be created for inflow of investment to biotechnological startups?
● What should the integration of government, universities, labs, and industrial partners be like?
● What do innovation startups focus on now?
Moderator:
Pekka Viljakainen — Advisor to the Chairman of the Board of Directors, Skolkovo Foundation; Chairman, Aii Capital
Mr. Pekka A. Viljakainen was born in Finland 1972. He studied engineering at the University of Technology in Lappeenranta. For 25 years worked as an ambassador between business executives and technology teams. He started as an entrepreneur in 1986, by establishing Oy Visual Systems Ltd. (1986-2004). His company was merged with TietoEnator in 2000. Mr. Viljakainen is widely known by his nickname, Bulldozer. The nickname was earned by his reputation and track record for handling very complex governance and political topics inside large international organizations. During his corporate carrier he acted as trusted advisor for CEO’s and chairman’s specializing for the transformation related to enterprise digitalization and HR.
After 26 years of his active Visual Systems-Tieto carrier, he left from operative roles on 2011 and focused to his non-profit leadership education project called www.nofear-community.com . Because of this he has been visiting speaker and advisor for several international corporations and faculties (like IMD Business School).
Since 2012 Mr Viljakainen is acting as senior advisor for the president of Skolkovo Foundation. Since that among other directions of work, he has been acting as a founder and advisor for several nationwide entrepreneurship programs in Russian Federation. Startup Tour Open Innovations 2013-2018 (over 85 cities of Russia and CIS) and international conference Startup Village 2013-2018. During those programs he has build a strong network of entrepreneurs, local governmental institutions as well as universities across Russia and abroad.
Mr Viljakainen is the member of Strategic Board of the Russian Postal Service and member of the Supervisory Board of PAO “Pochta Bank”. Chairman of the Board of ‘’Skolkovo – Venture Investments’’, Chairman of the Board “ZYFRA”.
Mr Viljakainen is also known as investor, business angel and advisor for several high-tech companies. Those activities are handled thru his family investment office called www.Aii.fi
He is also well known supporter and philanthropic for several areas related to education, classical music as well as several social projects. His hobbies are helicopter flying PPL(H), cross country skiing, weight lifting and triathlon.
After 26 years of his active Visual Systems-Tieto carrier, he left from operative roles on 2011 and focused to his non-profit leadership education project called www.nofear-community.com . Because of this he has been visiting speaker and advisor for several international corporations and faculties (like IMD Business School).
Since 2012 Mr Viljakainen is acting as senior advisor for the president of Skolkovo Foundation. Since that among other directions of work, he has been acting as a founder and advisor for several nationwide entrepreneurship programs in Russian Federation. Startup Tour Open Innovations 2013-2018 (over 85 cities of Russia and CIS) and international conference Startup Village 2013-2018. During those programs he has build a strong network of entrepreneurs, local governmental institutions as well as universities across Russia and abroad.
Mr Viljakainen is the member of Strategic Board of the Russian Postal Service and member of the Supervisory Board of PAO “Pochta Bank”. Chairman of the Board of ‘’Skolkovo – Venture Investments’’, Chairman of the Board “ZYFRA”.
Mr Viljakainen is also known as investor, business angel and advisor for several high-tech companies. Those activities are handled thru his family investment office called www.Aii.fi
He is also well known supporter and philanthropic for several areas related to education, classical music as well as several social projects. His hobbies are helicopter flying PPL(H), cross country skiing, weight lifting and triathlon.
Panellists:
Arkady Dvorkovich — Chairman, Skolkovo Foundation
Born on May 26, 1972 in Moscow.
In 1994 graduated from Moscow State University with a Master degree in economics.
1994-1997 – worked as an expert in the Expert Group of Russia’s Ministry of Finance.
1997-2000 - Head of the Economic Expert Group of Russia’s Ministry of Finance.
Since August of 2000 – Adviser of the Minister of Economic Development and Trade.
Since 2001 - Deputy Minister of Economic Development and Trade.
Since April of 2004 - Head of the Presidential Experts’ Directorate of the Presidential Executive Office.
Since May 13, 2008 - Aide to the President.
From May 13, 2008 to May, 21 2012 served as an aide to the President of the Russian Federation.
On December 31, 2009 according to the decree of the President Dmitry Medvedev entered the working group for creation of a detached territorial complex for research and development and further commercialization of the results.
On May 21, 2012 he was appointed the Deputy Prime-Minister of the Russian Federation.
May 2018 – appointed co-chair of the Skolkovo Foundation council.
In September 2018, he was appointed to a government commission on modernising Russia’s economy and innovative development.
The same month, he was appointed Chair of the Skolkovo Foundation.
In 1994 graduated from Moscow State University with a Master degree in economics.
1994-1997 – worked as an expert in the Expert Group of Russia’s Ministry of Finance.
1997-2000 - Head of the Economic Expert Group of Russia’s Ministry of Finance.
Since August of 2000 – Adviser of the Minister of Economic Development and Trade.
Since 2001 - Deputy Minister of Economic Development and Trade.
Since April of 2004 - Head of the Presidential Experts’ Directorate of the Presidential Executive Office.
Since May 13, 2008 - Aide to the President.
From May 13, 2008 to May, 21 2012 served as an aide to the President of the Russian Federation.
On December 31, 2009 according to the decree of the President Dmitry Medvedev entered the working group for creation of a detached territorial complex for research and development and further commercialization of the results.
On May 21, 2012 he was appointed the Deputy Prime-Minister of the Russian Federation.
May 2018 – appointed co-chair of the Skolkovo Foundation council.
In September 2018, he was appointed to a government commission on modernising Russia’s economy and innovative development.
The same month, he was appointed Chair of the Skolkovo Foundation.
Natalia Komarova — General Director, Rusatom Healthcare
Igor Korobko — Head of Science and Innovative Development of Health Department, Ministry of Health of the Russian Federation
(online)
Dmitry Kudlay — General Director, Generium
MD, professor
Academic background
University: Medical University, Novosibirsk
Department and Qualification: General medicine, doctor
Professional background
1996 - 1999 – Director, the hospital of the Ministry of Internal Affairs, Novosibirsk
2000 - 2004 – Managing positions in Marketing & Promotion, Russian pharmaceutical industry
2004 - 2013 – Deputy General Director (Marketing & Promotion), PHARMSTANDARD (the largest Russian pharmaceutical company)
2013 - present – General director, GENERIUM
Membership and Awards
• Member of the Government Subcommittee on the Circulation of Medicines
• Member of the working group on the Eurasian Economic Commission drug market, MoH
• Member of the Expert Council for the Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade
• Member of European Respiratory Society
• Winner of the Russian Federation Government Award
Dmitry Kudlay is the author of more than 70 scientific articles in peer-reviewed Russian and foreign publications.
Academic background
University: Medical University, Novosibirsk
Department and Qualification: General medicine, doctor
Professional background
1996 - 1999 – Director, the hospital of the Ministry of Internal Affairs, Novosibirsk
2000 - 2004 – Managing positions in Marketing & Promotion, Russian pharmaceutical industry
2004 - 2013 – Deputy General Director (Marketing & Promotion), PHARMSTANDARD (the largest Russian pharmaceutical company)
2013 - present – General director, GENERIUM
Membership and Awards
• Member of the Government Subcommittee on the Circulation of Medicines
• Member of the working group on the Eurasian Economic Commission drug market, MoH
• Member of the Expert Council for the Development of Pharmaceutical and Medical Industry, Ministry of Industry and Trade
• Member of European Respiratory Society
• Winner of the Russian Federation Government Award
Dmitry Kudlay is the author of more than 70 scientific articles in peer-reviewed Russian and foreign publications.
Sophie Park — Chief Strategy Officer, Bayer G4A
(online)
Robert Scott — Head of Product & Portfolio, Novartis Biome
(online)
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Noor Jandali — Analyst, Droobi Health, Qatar
Sergei Sorokin — General Director, Intellogic LLC; Founder, Botkin.AI
Has more than 10 years of experience in the field of information technology in healthcare. As the director of the healthcare division in Rostelecom PJSC, S. Sorokin took part in the development of services within the Unified State Healthcare Information System of the Russian Federation and other healthcare IT projects in Russia and abroad.
Since 2015, he has been the founder and CEO of the Russian company Intellogic LLC, currently developing the TeleMD platform project for diagnosing diseases with use of artificial intelligence. The company utilizes a unique technology to build AI-based mathematical patient representation models, allowing doctors to analyze the risks of various diseases (including cancer) and to perform their early diagnostics and detection.
Since 2015, he has been the founder and CEO of the Russian company Intellogic LLC, currently developing the TeleMD platform project for diagnosing diseases with use of artificial intelligence. The company utilizes a unique technology to build AI-based mathematical patient representation models, allowing doctors to analyze the risks of various diseases (including cancer) and to perform their early diagnostics and detection.
Vadim Tarasov — Director, Institute of Translational Medicine and Biotechnology